Categories

  • News, Press Release

    New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study

    Continue reading

  • News

    Priavoid selected to German Accelerator Program

    Continue reading

  • Event

    Prion 2022, Göttingen, 13-16 September

    Continue reading

  • Event

    Bio International, San Diego, 13-16 June

    Continue reading

  • Event

    Neuro4D, Mainz, 16-17 May

    Continue reading

  • News, Press Release

    Priavoid and Research Center Jülich receive funding from The Michael J. Fox Foundation

    Continue reading